vs
Side-by-side financial comparison of MEDIFAST INC (MED) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $75.1M, roughly 1.7× MEDIFAST INC). On growth, PagerDuty, Inc. posted the faster year-over-year revenue change (4.7% vs -36.9%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $-6.6M). Over the past eight quarters, PagerDuty, Inc.'s revenue compounded faster (5.9% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
MED vs PD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $124.5M |
| Net Profit | — | $161.6M |
| Gross Margin | 69.4% | 85.3% |
| Operating Margin | -10.4% | 6.5% |
| Net Margin | — | 129.7% |
| Revenue YoY | -36.9% | 4.7% |
| Net Profit YoY | — | 2827.7% |
| EPS (diluted) | $-1.64 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $124.5M | ||
| Q3 25 | $89.4M | $123.4M | ||
| Q2 25 | $105.6M | $119.8M | ||
| Q1 25 | $115.7M | $121.4M | ||
| Q4 24 | $119.0M | $118.9M | ||
| Q3 24 | $140.2M | $115.9M | ||
| Q2 24 | $168.6M | $111.2M | ||
| Q1 24 | $174.7M | $111.1M |
| Q4 25 | — | $161.6M | ||
| Q3 25 | $-2.3M | $9.6M | ||
| Q2 25 | $2.5M | $-7.2M | ||
| Q1 25 | $-772.0K | $-8.8M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $1.1M | $-10.9M | ||
| Q2 24 | $-8.2M | $-17.1M | ||
| Q1 24 | $8.3M | $-28.2M |
| Q4 25 | 69.4% | 85.3% | ||
| Q3 25 | 69.5% | 84.6% | ||
| Q2 25 | 72.6% | 84.0% | ||
| Q1 25 | 72.8% | 83.6% | ||
| Q4 24 | 74.1% | 83.0% | ||
| Q3 24 | 75.4% | 82.7% | ||
| Q2 24 | 73.2% | 82.6% | ||
| Q1 24 | 72.8% | 81.7% |
| Q4 25 | -10.4% | 6.5% | ||
| Q3 25 | -4.6% | 2.9% | ||
| Q2 25 | -1.0% | -8.6% | ||
| Q1 25 | -1.1% | -9.6% | ||
| Q4 24 | 0.6% | -8.7% | ||
| Q3 24 | 1.5% | -13.8% | ||
| Q2 24 | -4.7% | -19.5% | ||
| Q1 24 | 4.5% | -30.1% |
| Q4 25 | — | 129.7% | ||
| Q3 25 | -2.5% | 7.8% | ||
| Q2 25 | 2.3% | -6.0% | ||
| Q1 25 | -0.7% | -7.2% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | 0.8% | -9.4% | ||
| Q2 24 | -4.8% | -15.4% | ||
| Q1 24 | 4.8% | -25.3% |
| Q4 25 | $-1.64 | $1.69 | ||
| Q3 25 | $-0.21 | $0.10 | ||
| Q2 25 | $0.22 | $-0.07 | ||
| Q1 25 | $-0.07 | $-0.12 | ||
| Q4 24 | $0.08 | $-0.07 | ||
| Q3 24 | $0.10 | $-0.14 | ||
| Q2 24 | $-0.75 | $-0.26 | ||
| Q1 24 | $0.76 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $547.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $320.5M |
| Total Assets | $248.0M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $547.8M | ||
| Q3 25 | $173.5M | $567.9M | ||
| Q2 25 | $162.7M | $597.1M | ||
| Q1 25 | $164.6M | $570.8M | ||
| Q4 24 | $162.3M | $542.2M | ||
| Q3 24 | $170.0M | $599.3M | ||
| Q2 24 | $163.5M | $592.8M | ||
| Q1 24 | $156.4M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $489.5M |
| Q4 25 | $198.9M | $320.5M | ||
| Q3 25 | $214.7M | $180.7M | ||
| Q2 25 | $216.0M | $145.7M | ||
| Q1 25 | $211.0M | $129.8M | ||
| Q4 24 | $210.1M | $111.6M | ||
| Q3 24 | $207.3M | $164.7M | ||
| Q2 24 | $205.3M | $174.0M | ||
| Q1 24 | $211.0M | $171.6M |
| Q4 25 | $248.0M | $1.0B | ||
| Q3 25 | $268.2M | $891.5M | ||
| Q2 25 | $269.3M | $926.8M | ||
| Q1 25 | $280.0M | $927.3M | ||
| Q4 24 | $284.2M | $866.8M | ||
| Q3 24 | $291.2M | $916.0M | ||
| Q2 24 | $293.5M | $924.0M | ||
| Q1 24 | $302.8M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $24.8M |
| Free Cash FlowOCF − Capex | $-6.6M | $24.1M |
| FCF MarginFCF / Revenue | -8.8% | 19.3% |
| Capex IntensityCapex / Revenue | 1.8% | 0.6% |
| Cash ConversionOCF / Net Profit | — | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $24.8M | ||
| Q3 25 | $12.1M | $34.0M | ||
| Q2 25 | $-3.4M | $30.7M | ||
| Q1 25 | $3.4M | $31.4M | ||
| Q4 24 | $-4.9M | $22.1M | ||
| Q3 24 | $9.1M | $35.8M | ||
| Q2 24 | $13.1M | $28.6M | ||
| Q1 24 | $7.3M | $22.2M |
| Q4 25 | $-6.6M | $24.1M | ||
| Q3 25 | $10.8M | $33.1M | ||
| Q2 25 | $-4.8M | $30.2M | ||
| Q1 25 | $1.9M | $30.3M | ||
| Q4 24 | $-7.2M | $21.5M | ||
| Q3 24 | $7.7M | $35.1M | ||
| Q2 24 | $11.1M | $28.2M | ||
| Q1 24 | $5.4M | $21.2M |
| Q4 25 | -8.8% | 19.3% | ||
| Q3 25 | 12.0% | 26.8% | ||
| Q2 25 | -4.5% | 25.2% | ||
| Q1 25 | 1.6% | 24.9% | ||
| Q4 24 | -6.1% | 18.1% | ||
| Q3 24 | 5.5% | 30.3% | ||
| Q2 24 | 6.6% | 25.4% | ||
| Q1 24 | 3.1% | 19.1% |
| Q4 25 | 1.8% | 0.6% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 1.3% | 0.4% | ||
| Q1 25 | 1.3% | 0.9% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.0% | 0.5% | ||
| Q2 24 | 1.1% | 0.4% | ||
| Q1 24 | 1.1% | 0.9% |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 3.55× | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
